Published in Cochrane Database Syst Rev on May 31, 2014
Early chronic kidney disease: diagnosis, management and models of care. Nat Rev Nephrol (2015) 0.98
Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.89
Lipid abnormalities in kidney disease and management strategies. World J Nephrol (2015) 0.88
Cholesterol Metabolism in CKD. Am J Kidney Dis (2015) 0.84
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein. Arch Med Res (2015) 0.79
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Sao Paulo Med J (2015) 0.78
The association between individual counselling and health behaviour change: the See Kidney Disease (SeeKD) targeted screening programme for chronic kidney disease. Can J Kidney Health Dis (2016) 0.78
Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease. Pediatr Nephrol (2016) 0.76
A meta-analysis of the effects of statin treatment on cardiovascular events and all-cause mortality in diabetic dialysis patients. Int J Clin Exp Med (2015) 0.76
Diabetes: statins for microvascular complications-all but the kidney. Nat Rev Nephrol (2014) 0.75
Endovascular versus medical therapy for atherosclerotic renovascular disease. Curr Atheroscler Rep (2014) 0.75
Statins for chronic kidney disease not requiring dialysis. Nephrology (Carlton) (2015) 0.75
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD. Nat Rev Nephrol (2017) 0.75
Global cardiovascular protection in chronic kidney disease. Nat Rev Cardiol (2016) 0.75
Mechanisms and consequences of carbamoylation. Nat Rev Nephrol (2017) 0.75
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function. J Am Soc Nephrol (2017) 0.75
Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans. Int Urol Nephrol (2017) 0.75
Lipid lowering in renal disease. Aust Prescr (2017) 0.75
Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int (2010) 12.06
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med (2014) 10.66
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2012) 6.38
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet (2010) 6.23
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis (2007) 5.84
A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med (2004) 5.02
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med (2009) 4.90
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet (2009) 4.73
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med (2009) 4.35
Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23
Long-term survival of children with end-stage renal disease. N Engl J Med (2004) 4.10
Clinical trials in children. Lancet (2004) 3.97
ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int (2011) 3.88
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ (2009) 3.83
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics (2014) 3.52
The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis (2008) 3.45
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. Am J Kidney Dis (2005) 3.37
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol (2004) 3.30
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med (2010) 3.18
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med (2009) 2.79
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust (2007) 2.68
Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis. Pediatrics (2010) 2.68
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2011) 2.46
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J (2008) 2.41
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol (2012) 2.30
Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17
Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)--a randomized placebo-controlled trial. Am Heart J (2013) 2.12
Measuring the quality of public open space using Google Earth. Am J Prev Med (2011) 2.11
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One (2013) 2.10
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care (2013) 2.07
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2009) 2.04
Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med (2004) 2.03
Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis (2012) 1.97
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int (2010) 1.89
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89
Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2009) 1.88
The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients. Ann Surg Oncol (2008) 1.87
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med (2009) 1.86
Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84
Interleukin-1beta induces human proximal tubule cell injury, alpha-smooth muscle actin expression and fibronectin production. Kidney Int (2002) 1.84
Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis (2010) 1.81